Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Uniporter
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Large neutral amino acid transporter (LAT1) === [[File:Protein SLC3A2 PDB 2dh2.png|thumb|SLC3 protein coding gene for LAT1]] The '''L-type amino acid transporter (LAT1)''' is a uniporter that mediates the transport of [[Neutral amino acid transporter A|neutral amino acids]] like [[Tryptophan|L-tryptophan]], [[leucine]], [[histidine]], [[proline]], [[alanine]], etc.<ref name="Häfliger P">{{cite journal |vauthors=Häfliger P, Charles RP |title=The L-Type Amino Acid Transporter LAT1-An Emerging Target in Cancer |journal=Int J Mol Sci |volume=20 |issue=10 |date=May 2019 |page=2428 |pmid=31100853 |pmc=6566973 |doi=10.3390/ijms20102428 |doi-access=free }}</ref> [[CD98|LAT1]] favors the transport of amino acids with large branched or [[Amino acid|aromatic side chains]]. The amino acid transporter functions to move essential amino acids into the [[intestinal epithelium]], [[placenta]], and [[Blood–brain barrier|blood-brain barrier]] for cellular processes such as metabolism and cell signaling.<ref name="Bhutia YD">{{cite journal |vauthors=Bhutia YD, Mathew M, Sivaprakasam S, Ramachandran S, Ganapathy V |title=Unconventional Functions of Amino Acid Transporters: Role in Macropinocytosis (SLC38A5/SLC38A3) and Diet-Induced Obesity/Metabolic Syndrome (SLC6A19/SLC6A14/SLC6A6) |journal=Biomolecules |volume=12 |issue=2 |date=January 2022 |page=235 |pmid=35204736 |pmc=8961558 |doi=10.3390/biom12020235 |doi-access=free }}</ref> The transporter is of particular significance in the [[central nervous system]] as it provides the necessary amino acids for protein synthesis and [[Neurotransmitter|neurotransmitter production]] in brain cells.<ref name="Bhutia YD" /> [[Aromatic amino acid]]s like [[phenylalanine]] and [[tryptophan]] are precursors for neurotransmitters like [[dopamine]], [[serotonin]], and [[norepinephrine]].<ref name="Bhutia YD" /> LAT1 is a membrane protein of the [[SLC7A14|SLC7]] family of transporters and works in conjunction with the [[Solute carrier family|SLC3 family]] member [[4F2 cell-surface antigen heavy chain|4F2hc]] to form a [[Protein dimer|heterodimeric]] complex known as the 4F2hc complex.<ref name="Häfliger P" /> The heterodimer consists of a light chain and a heavy chain [[Covalent bond|covalently bonded]] by a [[disulfide bond]]. The light chain is the one that carries out transport, while the heavy chain is needed to stabilize the dimer.<ref name="Häfliger P" /> There is some controversy over whether LAT1 is an uniporter or an [[antiporter]]. The transporter has uniporter characteristics of transporting amino acids into cells in a unidirectional manner down the concentration gradient. However, recently it has been found that the transporter has antiporter characteristics of exchanging neutral amino acids for abundant intracellular amino acids.<ref>{{cite journal |vauthors=Singh N, Ecker GF |title=Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1 |journal=Int J Mol Sci |volume=19 |issue=5 |date=April 2018 |page=1278 |pmid=29695141 |pmc=5983779 |doi=10.3390/ijms19051278 |doi-access=free }}</ref> Over-expression of LAT1 has been found in human [[cancer]] and is associated with playing a role in cancer metabolism.<ref>{{cite journal |vauthors=Kanai Y |title=Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics |journal=Pharmacol Ther |volume=230 |issue= |pages=107964 |date=February 2022 |pmid=34390745 |doi=10.1016/j.pharmthera.2021.107964 }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)